Track topics on Twitter Track topics that are important to you
Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic antibody biotechnology through over-the-counter medicines to consumer healthcare products.
Chugai is currently the 5th ranked pharmaceutical company in Japan in terms of sales, (the world’s second largest pharmaceutical market after the USA).
On 1st October 2002, Chugai Pharmaceutical Co became a member of the Roche Group, and is Roche’s sole representative in Japan following the integration of Nippon Roche and Chugai.
One of the first examples of specific collaboration between Chugai and Roche is that of MRA: Chugai’s monoclonal antibody in development for the treatment of a number of conditions (eg Rheumatoid Arthritis).
Chugai conducts research at its Japanese research sites employing cutting-edge techniques for identification of small molecule and biological therapeutic candidates.
Phone: 44 (0) 20 8987 5600
Fax: 44 (0) 20 8987 5660
A failure to embrace biologics R&D has restricted Japanese pharma’s global growth, says CEO of Roche subsidiary Chugai Pharmaceuticals.
Japanese drug major Chugai Pharmaceutical today announced that an arbitration against Chugai has been…
Roche and UK-based Chugai Pharmaceutical have reported positive data from the Phase III HAVEN 1 clinical trial of emicizumab in patients suffering from haemophilia A.
Japan’s Chugai Pharmaceutical saw its shares gain 2.15% to 4,515 yen, after it revealed legislation…
Chugai has filed an application with the Japanese Ministry of Health, Labor and Welfare (MHLW) for the…
Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the US Food and Drugs Administration (FDA) has accepted the Biologics License Application (BLA) and has gr...
Japan’s Chugai Pharmaceutical is to sell 13 so-called long-listed products - branded drugs that are…
Chugai Pharma USA, Inc. (CPUSA), a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) leading the planning and execution of early-stage global clinical...
Fluoride Chewable Tablets 0.5 mg
Fluoride Chewable Tablets 1 mg
Metoprolol Tartrate Tablets, USP
Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )
After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...
Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using differe...
To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.
The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...
Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...
THE STUDY WILL BE A TWO-PART RESEARCH PART A and PART A extended: 1. To implement a "common" MRI acquisition protocol in multiple centers across Europe (Pharma-COG partners)...
Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...
European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.
Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic anti...
Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...
Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around...
We have published hundreds of Chugai Pharma Europe Ltd news stories on BioPortfolio along with dozens of Chugai Pharma Europe Ltd Clinical Trials and PubMed Articles about Chugai Pharma Europe Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chugai Pharma Europe Ltd Companies in our database. You can also find out about relevant Chugai Pharma Europe Ltd Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...